FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128900479> ?p ?o ?g. }

• W3128900479 abstract "Background Despite recent advancements in the treatment of acute ischemic stroke (AIS) with large vessel occlusion (LVO), infarct progression over time and functional outcomes remain variable. This variation in outcomes may be partially attributed to an underlying state of chronic cerebral hypoperfusion and ischemia affecting small cerebral perforating arterioles, venules, and capillaries of the brain; broadly termed cerebral small vessel disease (CSVD). We investigated the association between CSVD burden and the degree of disability following successful recanalization with endovascular thrombectomy (EVT) in patients with AIS presenting with LVO. Methodology We conducted a single center retrospective analysis of all patients presenting with AIS LVO between May 2016 and May 2019. Patients who were premorbidly independent and presented within six hours from the last known well (LKW) with a proximal anterior circulation occlusion confirmed on computed tomography (CT) angiography of the head or neck were treated with EVT. Patients presenting after six hours and up to 24 hours from LKW with a target ischemic core to perfusion mismatch profile on CT or magnetic resonance (MR) perfusion, or a clinical imaging mismatch on MR diffusion-weighted imaging, were also treated. Patients with successful revascularization, defined as a thrombolysis in cerebral infarction score 2b or 3, were included and evaluated for CSVD burden. The presence of CSVD was quantified using the Fazekas scale (0-3). All patients were further evaluated for disability at 90 days using the modified Rankin Scale (mRS, range 0-6). An mRS score of ≤2 was defined as a good functional outcome. Results Of the 190 patients evaluated, absent (Fazekas grade 0), mild (Fazekas grade 1), moderate (Fazekas grade 2), and severe (Fazekas grade 3) CSVD was present in 33 (17.4%), 84 (44.2%), 35 (18.4%), and 38 (20.0%) patients, respectively. Patients with severe CSVD (Fazekas grade 3) were found to be older, had a higher presenting National Institute of Health Stroke Scale (NIHSS), and had greater proportions of preexisting atrial fibrillation and dementia compared to patients with no CSVD (Fazekas grade 0). Using a multivariate ordinal logistic regression model to adjust for age, presenting NIHSS, thrombus location, LKW to groin puncture time, use of tissue plasminogen activator, ischemic infarct volume, development of a symptomatic intracerebral hemorrhage, and treatment with hemicraniectomy, patients with Fazekas grade 3 were significantly more likely to have poor 90-day functional outcomes compared to patients with Fazekas grade 0 (odds ratio 10.25, 95% confidence interval [3.3-31.84]). Conclusions Based on our analytical cohort of AIS LVO patients treated with EVT, we found that patients with severe CSVD burden had worse functional outcomes at 90 days and increased mortality. These results provide evidence that the burden of CSVD may be considered an independent risk factor of poor clinical outcome and a predictor of mortality in patients with AIS presenting with LVO, despite successful radiographic recanalization with EVT." @default.
• W3128900479 created "2021-02-15" @default.
• W3128900479 creator A5028843482 @default.
• W3128900479 creator A5028991618 @default.
• W3128900479 creator A5032127885 @default.
• W3128900479 creator A5038480788 @default.
• W3128900479 creator A5039072491 @default.
• W3128900479 creator A5046922989 @default.
• W3128900479 creator A5050330145 @default.
• W3128900479 creator A5053331010 @default.
• W3128900479 creator A5056714321 @default.
• W3128900479 creator A5058713131 @default.
• W3128900479 date "2021-02-04" @default.
• W3128900479 modified "2023-10-13" @default.
• W3128900479 title "Severe Cerebral Small Vessel Disease Burden Is Associated With Poor Outcomes After Endovascular Thrombectomy in Acute Ischemic Stroke With Large Vessel Occlusion" @default.
• W3128900479 cites W2060478433 @default.
• W3128900479 cites W2075389323 @default.
• W3128900479 cites W2077851540 @default.
• W3128900479 cites W2091931051 @default.
• W3128900479 cites W2137316798 @default.
• W3128900479 cites W2143212953 @default.
• W3128900479 cites W2148745554 @default.
• W3128900479 cites W2195786942 @default.
• W3128900479 cites W2269790923 @default.
• W3128900479 cites W2277258071 @default.
• W3128900479 cites W2336407211 @default.
• W3128900479 cites W2493756592 @default.
• W3128900479 cites W2518794452 @default.
• W3128900479 cites W2561699212 @default.
• W3128900479 cites W2563179587 @default.
• W3128900479 cites W2580705107 @default.
• W3128900479 cites W2581236536 @default.
• W3128900479 cites W2752526990 @default.
• W3128900479 cites W2767776410 @default.
• W3128900479 cites W2787867590 @default.
• W3128900479 cites W2793336465 @default.
• W3128900479 cites W2884132908 @default.
• W3128900479 cites W2886213212 @default.
• W3128900479 cites W2891019753 @default.
• W3128900479 cites W2906952623 @default.
• W3128900479 cites W2964142051 @default.
• W3128900479 cites W2972977858 @default.
• W3128900479 cites W3028887433 @default.
• W3128900479 doi "https://doi.org/10.7759/cureus.13122" @default.
• W3128900479 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7935286" @default.
• W3128900479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33728139" @default.
• W3128900479 hasPublicationYear "2021" @default.
• W3128900479 type Work @default.
• W3128900479 sameAs 3128900479 @default.
• W3128900479 citedByCount "2" @default.
• W3128900479 countsByYear W31289004792022 @default.
• W3128900479 crossrefType "journal-article" @default.
• W3128900479 hasAuthorship W3128900479A5028843482 @default.
• W3128900479 hasAuthorship W3128900479A5028991618 @default.
• W3128900479 hasAuthorship W3128900479A5032127885 @default.
• W3128900479 hasAuthorship W3128900479A5038480788 @default.
• W3128900479 hasAuthorship W3128900479A5039072491 @default.
• W3128900479 hasAuthorship W3128900479A5046922989 @default.
• W3128900479 hasAuthorship W3128900479A5050330145 @default.
• W3128900479 hasAuthorship W3128900479A5053331010 @default.
• W3128900479 hasAuthorship W3128900479A5056714321 @default.
• W3128900479 hasAuthorship W3128900479A5058713131 @default.
• W3128900479 hasBestOaLocation W31289004791 @default.
• W3128900479 hasConcept C126322002 @default.
• W3128900479 hasConcept C126838900 @default.
• W3128900479 hasConcept C127413603 @default.
• W3128900479 hasConcept C135691158 @default.
• W3128900479 hasConcept C143409427 @default.
• W3128900479 hasConcept C146957229 @default.
• W3128900479 hasConcept C164705383 @default.
• W3128900479 hasConcept C2776268601 @default.
• W3128900479 hasConcept C2778212899 @default.
• W3128900479 hasConcept C2779464278 @default.
• W3128900479 hasConcept C2779581417 @default.
• W3128900479 hasConcept C2780643987 @default.
• W3128900479 hasConcept C2780645631 @default.
• W3128900479 hasConcept C2780931571 @default.
• W3128900479 hasConcept C3020199598 @default.
• W3128900479 hasConcept C500558357 @default.
• W3128900479 hasConcept C541997718 @default.
• W3128900479 hasConcept C71924100 @default.
• W3128900479 hasConcept C78519656 @default.
• W3128900479 hasConceptScore W3128900479C126322002 @default.
• W3128900479 hasConceptScore W3128900479C126838900 @default.
• W3128900479 hasConceptScore W3128900479C127413603 @default.
• W3128900479 hasConceptScore W3128900479C135691158 @default.
• W3128900479 hasConceptScore W3128900479C143409427 @default.
• W3128900479 hasConceptScore W3128900479C146957229 @default.
• W3128900479 hasConceptScore W3128900479C164705383 @default.
• W3128900479 hasConceptScore W3128900479C2776268601 @default.
• W3128900479 hasConceptScore W3128900479C2778212899 @default.
• W3128900479 hasConceptScore W3128900479C2779464278 @default.
• W3128900479 hasConceptScore W3128900479C2779581417 @default.
• W3128900479 hasConceptScore W3128900479C2780643987 @default.
• W3128900479 hasConceptScore W3128900479C2780645631 @default.
• W3128900479 hasConceptScore W3128900479C2780931571 @default.
• W3128900479 hasConceptScore W3128900479C3020199598 @default.
• W3128900479 hasConceptScore W3128900479C500558357 @default.
• W3128900479 hasConceptScore W3128900479C541997718 @default.
• W3128900479 hasConceptScore W3128900479C71924100 @default.

• next